The publication of the National Institute of Neurological Disorders and blow trial of thrombolysis has not l to the widespread implementation of alteplase for acute ischaemic misfortune in the United Kingdom.The publication of the National Institute of Neurological Disorders and blow trial of thrombolysis has not l to the widespread implementation of alteplase for acute ischaemic misfortune in the United Kingdom. However, the Cochrane systematic review of thrombolysis for acute ischaemic hit suggests that alteplase is the mostly promising treatment for acute ischaemic thump Successful implementation of thrombolysis in the United Kingdom will hang on continued investment in acute visitation services, attention to the known barriers to treatment, further data from randomized controll trials and the licensing of alteplase for this indication. COPYRIGHT 2002 Oxford University Press |
| Home |
